In accordance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025 (‘SEBI Circular’) in respect of ‘Ease of Doing Investment - Special Window for Re-lodgement of Transfer Requests of Physical Shares’, Bharat Parenterals has informed that it enclosed Report dated December 08, 2025 received from the Company's Registrar and Transfer Agent, Adroit Corporate Services, regarding transfer requests for physical shares that were re-lodged for transfer cum demat during the period from November 01, 2025 to November 30, 2025, under the special window provided by the SEBI Circular.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.40 |
| Dr. Reddys Lab | 1213.60 |
| Cipla | 1225.95 |
| Zydus Lifesciences | 930.95 |
| Lupin | 2336.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: